Literature DB >> 12427574

Biomarkers in psychiatry: methodological issues.

Helena Chmura Kraemer1, Susan K Schultz, Stephan Arndt.   

Abstract

Particularly in psychiatry, biological measures are increasingly sought to detect exposure to toxic agents, to assist in early identification of illness, and to enhance diagnostic certainty, provide prognostic information, and permit the mapping of outcome in a variety of disorders. The authors explore the fundamental criteria necessary to designate a biological measure as a "biomarker" and discuss the potential applications, limitations, and hazards of such markers. Authors discuss methods for establishing the validity of a biomarker. Finally, they convey a word of caution about overinterpreting the clinical or scientific value of any biological measure.

Mesh:

Substances:

Year:  2002        PMID: 12427574

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  16 in total

Review 1.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

2.  Is late-onset schizophrenia a subtype of schizophrenia?

Authors:  I V Vahia; B W Palmer; C Depp; I Fellows; S Golshan; H C Kraemer; Dilip V Jeste
Journal:  Acta Psychiatr Scand       Date:  2010-11       Impact factor: 6.392

3.  The feasibility of ambulatory biosensor measurement of salivary alpha amylase: Relationships with self-reported and naturalistic psychological stress.

Authors:  Theodore F Robles; Vivek Shetty; Corwin M Zigler; Dorie A Glover; David Elashoff; Debra Murphy; Masaki Yamaguchi
Journal:  Biol Psychol       Date:  2010-10-16       Impact factor: 3.251

4.  Tracking biocultural pathways in population health: the value of biomarkers.

Authors:  Carol M Worthman; E Jane Costello
Journal:  Ann Hum Biol       Date:  2009 May-Jun       Impact factor: 1.533

Review 5.  Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V.

Authors:  Mary L Phillips; Eduard Vieta
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

Review 6.  Removing obstacles in neuroscience drug discovery: the future path for animal models.

Authors:  Athina Markou; Christian Chiamulera; Mark A Geyer; Mark Tricklebank; Thomas Steckler
Journal:  Neuropsychopharmacology       Date:  2008-10-01       Impact factor: 7.853

7.  Prefrontal cortical and striatal activity to happy and fear faces in bipolar disorder is associated with comorbid substance abuse and eating disorder.

Authors:  Stefanie Hassel; Jorge R Almeida; Ellen Frank; Amelia Versace; Sharon A Nau; Crystal R Klein; David J Kupfer; Mary L Phillips
Journal:  J Affect Disord       Date:  2009-02-24       Impact factor: 4.839

Review 8.  Personalized medicine in psychiatry: problems and promises.

Authors:  Uzoezi Ozomaro; Claes Wahlestedt; Charles B Nemeroff
Journal:  BMC Med       Date:  2013-05-16       Impact factor: 8.775

9.  Stress biomarkers as outcomes for HIV+ prevention: participation, feasibility and findings among HIV+ Latina and African American mothers.

Authors:  Dorie A Glover; Elena F Garcia-Aracena; Patricia Lester; Eric Rice; Mary Jane Rothram-Borus
Journal:  AIDS Behav       Date:  2009-04-07

10.  Biomarkers in psychiatry: how close are we?

Authors:  Firas Kobeissy; Ali Alawieh; Stefania Mondello; Rose-Mary Boustany; Mark S Gold
Journal:  Front Psychiatry       Date:  2013-01-07       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.